GenomeNet

Database: UniProt
Entry: Q8IZF2
LinkDB: Q8IZF2
Original site: Q8IZF2 
ID   AGRF5_HUMAN             Reviewed;        1346 AA.
AC   Q8IZF2; O94858; Q5TF06; Q6RGN2; Q86SP0; Q9Y3Z2;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   04-NOV-2026, entry version 196.
DE   RecName: Full=Adhesion G protein-coupled receptor F5 {ECO:0000303|PubMed:25713288};
DE   AltName: Full=G protein-coupled receptor 116;
DE   Flags: Precursor;
GN   Name=ADGRF5 {ECO:0000312|HGNC:HGNC:19030}; Synonyms=GPR116, KIAA0758;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=12435584; DOI=10.1016/s0014-5793(02)03574-3;
RA   Fredriksson R., Lagerstroem M.C., Hoeglund P.J., Schioeth H.B.;
RT   "Novel human G protein-coupled receptors with long N-terminals containing
RT   GPS domains and Ser/Thr-rich regions.";
RL   FEBS Lett. 531:407-414(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-604.
RC   TISSUE=Brain;
RA   Bonner T.I., Nagle J.W., Kauffman D.;
RT   "Complete coding sequence of GPR116.";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS MET-604
RP   AND THR-856.
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Ishikawa K., Suyama M.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-613 (ISOFORM 1), AND VARIANTS MET-604 AND ILE-801.
RC   TISSUE=Brain, and Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS MET-604
RP   AND THR-856.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 949-1062.
RX   PubMed=12679517; DOI=10.1073/pnas.0230374100;
RA   Vassilatis D.K., Hohmann J.G., Zeng H., Li F., Ranchalis J.E.,
RA   Mortrud M.T., Brown A., Rodriguez S.S., Weller J.R., Wright A.C.,
RA   Bergmann J.E., Gaitanaris G.A.;
RT   "The G protein-coupled receptor repertoires of human and mouse.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4903-4908(2003).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-256 AND ASN-315.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=23590306; DOI=10.1165/rcmb.2012-0439oc;
RA   Bridges J.P., Ludwig M.G., Mueller M., Kinzel B., Sato A., Xu Y.,
RA   Whitsett J.A., Ikegami M.;
RT   "Orphan G protein-coupled receptor GPR116 regulates pulmonary surfactant
RT   pool size.";
RL   Am. J. Respir. Cell Mol. Biol. 49:348-357(2013).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=23684610; DOI=10.1016/j.celrep.2013.04.019;
RA   Yang M.Y., Hilton M.B., Seaman S., Haines D.C., Nagashima K., Burks C.M.,
RA   Tessarollo L., Ivanova P.T., Brown H.A., Umstead T.M., Floros J.,
RA   Chroneos Z.C., St Croix B.;
RT   "Essential regulation of lung surfactant homeostasis by the orphan G
RT   protein-coupled receptor GPR116.";
RL   Cell Rep. 3:1457-1464(2013).
RN   [12]
RP   NOMENCLATURE.
RX   PubMed=25713288; DOI=10.1124/pr.114.009647;
RA   Hamann J., Aust G., Arac D., Engel F.B., Formstone C., Fredriksson R.,
RA   Hall R.A., Harty B.L., Kirchhoff C., Knapp B., Krishnan A., Liebscher I.,
RA   Lin H.H., Martinelli D.C., Monk K.R., Peeters M.C., Piao X., Promel S.,
RA   Schoneberg T., Schwartz T.W., Singer K., Stacey M., Ushkaryov Y.A.,
RA   Vallon M., Wolfrum U., Wright M.W., Xu L., Langenhan T., Schioth H.B.;
RT   "International union of basic and clinical pharmacology. XCIV. Adhesion G
RT   protein-coupled receptors.";
RL   Pharmacol. Rev. 67:338-367(2015).
RN   [13]
RP   FUNCTION, IDENTIFICATION OF THE TETHERED LIGAND, AND TISSUE SPECIFICITY.
RX   PubMed=28570277; DOI=10.1172/jci.insight.93700;
RA   Brown K., Filuta A., Ludwig M.G., Seuwen K., Jaros J., Vidal S., Arora K.,
RA   Naren A.P., Kandasamy K., Parthasarathi K., Offermanns S., Mason R.J.,
RA   Miller W.E., Whitsett J.A., Bridges J.P.;
RT   "Epithelial Gpr116 regulates pulmonary alveolar homeostasis via Gq/11
RT   signaling.";
RL   JCI Insight 2:0-0(2017).
RN   [14]
RP   IDENTIFICATION AS FNDC4 RECEPTOR, AND TISSUE SPECIFICITY.
RX   PubMed=34016966; DOI=10.1038/s41467-021-22579-1;
RA   Georgiadi A., Lopez-Salazar V., Merahbi R.E., Karikari R.A., Ma X.,
RA   Mourao A., Klepac K., Buehler L., Alfaro A.J., Kaczmarek I., Linford A.,
RA   Bosma M., Shilkova O., Ritvos O., Nakamura N., Hirose S., Lassi M.,
RA   Teperino R., Machado J., Scheideler M., Dietrich A., Geerlof A.,
RA   Feuchtinger A., Blutke A., Fischer K., Mueller T.D., Kessler K.,
RA   Schoeneberg T., Thor D., Hornemann S., Kruse M., Nawroth P.,
RA   Pivovarova-Ramich O., Pfeiffer A.F.H., Sattler M., Blueher M., Herzig S.;
RT   "Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine
RT   FNDC4 in adipose tissue.";
RL   Nat. Commun. 12:2999-2999(2021).
RN   [15]
RP   MUTAGENESIS OF 991-THR--LEU-996; GLY-1009; 1075-GLN--ASN-1077;
RP   1080-ILE--LYS-1083; ARG-1153; THR-1157; VAL-1161; 1240-PHE--THR-1243;
RP   ALA-1252 AND VAL-1256.
RX   PubMed=36073784; DOI=10.7554/elife.69061;
RA   Bridges J.P., Safina C., Pirard B., Brown K., Filuta A., Panchanathan R.,
RA   Bouhelal R., Reymann N., Patel S., Seuwen K., Miller W.E., Ludwig M.G.;
RT   "Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5
RT   requires a tethered agonist-mediated activation mechanism.";
RL   Elife 11:0-0(2022).
CC   -!- FUNCTION: Adhesion G protein-coupled receptor (PubMed:28570277). In
CC       alveolar type II (ATII or AT2) cells, required for normal lung
CC       surfactant homeostasis (PubMed:28570277). Modulation of both surfactant
CC       secretion and uptake by ATII cells is mediated by the downstream
CC       activation of GNAQ/GNA11 proteins and may be a consequence of increased
CC       cortical F-actin assembly induced by ADGRF5 activation
CC       (PubMed:28570277). In the kidney, may play a role in the regulation of
CC       acid excretion into the primary urine, possibly by regulating the
CC       surface expression of V-ATPase proton pump (By similarity). As a
CC       receptor for soluble FNDC4 (sFNDC4), required for proper systemic
CC       glucose tolerance, specifically sensitizing white adipose tissue to
CC       insulin. Also plays a role in sFNDC4-induced decrease of local
CC       inflammation in white adipose tissue (PubMed:34016966).
CC       {ECO:0000250|UniProtKB:G5E8Q8, ECO:0000269|PubMed:28570277,
CC       ECO:0000269|PubMed:34016966}.
CC   -!- ACTIVITY REGULATION: As an adhesion G protein-coupled receptor (aGPCR)
CC       exhibits a large N-terminal extracellular domain containing highly
CC       conserved GPCR autoproteolysis-inducing (GAIN) domain. During
CC       synthesis, intracellular autoproteolytic processing of nascent chain
CC       within the GAIN domain generates a mature protein, consisting of an N-
CC       terminal fragment that is non-covalently linked to the C-terminal
CC       fragment. The mature protein is routed to the plasma membrane where the
CC       N- and C-terminal fragments remain associated, forming the
CC       holoreceptor. Dissociation of the aGPCR fragments stimulates G protein
CC       signaling through the action of the tethered-peptide agonist stalk that
CC       is occluded within the GAIN domain in the holoreceptor form. This
CC       dissociation might be induced by ligand binding, such as that of
CC       sFNDC4. {ECO:0000305}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Heterodimer of 2 chains generated
CC       by proteolytic processing; the large extracellular N-terminal fragment
CC       and the membrane-bound C-terminal fragment predominantly remain
CC       associated and non-covalently linked. Fragment generates by the
CC       processing enzyme furin remains attached to the extracellular N-
CC       terminal fragment. Interacts (via N-terminal extracellular domain) with
CC       SFTPD. {ECO:0000250|UniProtKB:G5E8Q8, ECO:0000250|UniProtKB:Q9WVT0}.
CC   -!- INTERACTION:
CC       Q8IZF2; Q9NPB3: CABP2; NbExp=3; IntAct=EBI-7600130, EBI-12011224;
CC       Q8IZF2; Q53EP0-3: FNDC3B; NbExp=3; IntAct=EBI-7600130, EBI-10242151;
CC       Q8IZF2; Q13952-2: NFYC; NbExp=3; IntAct=EBI-7600130, EBI-11956831;
CC       Q8IZF2; P55735-3: SEC13; NbExp=3; IntAct=EBI-7600130, EBI-12235008;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23590306,
CC       ECO:0000269|PubMed:23684610}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IZF2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IZF2-2; Sequence=VSP_010837, VSP_010838;
CC       Name=3;
CC         IsoId=Q8IZF2-3; Sequence=VSP_039130;
CC   -!- TISSUE SPECIFICITY: Expressed in lung endothelial cells and in alveolar
CC       type II (ATII) cells (at protein level) (PubMed:23684610,
CC       PubMed:28570277). Expressed high levels in subcutaneous adipose tissue
CC       in lean individuals and at lower levels in visceral fat. Expression
CC       levels in subcutaneous adipose tissue drastically drop in obese
CC       individuals (PubMed:34016966). {ECO:0000269|PubMed:23684610,
CC       ECO:0000269|PubMed:28570277, ECO:0000269|PubMed:34016966}.
CC   -!- PTM: Highly glycosylated. {ECO:0000250|UniProtKB:Q9WVT0}.
CC   -!- PTM: Proteolytically cleaved at multiple sites: one in the GPS region
CC       of the GAIN-B domain (S1 site) and the other in the SEA domain (S2
CC       site). The proteolytic cleavage at S1 site generates an extracellular
CC       subunit and a seven-transmembrane subunit. The proteolytic cleavage at
CC       S2 site generates a fragment that undergoes proteolytic cleavage by the
CC       processing enzyme furin. {ECO:0000250|UniProtKB:Q9WVT0}.
CC   -!- SIMILARITY: Belongs to the G protein-coupled receptor 2 family.
CC       Adhesion G protein-coupled receptor (ADGR) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34478.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB43394.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY140958; AAN46672.1; -; mRNA.
DR   EMBL; AY498875; AAS21061.1; -; mRNA.
DR   EMBL; AB018301; BAA34478.2; ALT_INIT; mRNA.
DR   EMBL; AL050295; CAB43394.1; ALT_SEQ; mRNA.
DR   EMBL; AL832125; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL096772; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC066121; AAH66121.1; -; mRNA.
DR   EMBL; AY255552; AAO85064.1; -; mRNA.
DR   CCDS; CCDS4919.1; -. [Q8IZF2-1]
DR   PIR; T08685; T08685.
DR   RefSeq; NP_001091988.1; NM_001098518.2. [Q8IZF2-1]
DR   RefSeq; NP_056049.4; NM_015234.5. [Q8IZF2-1]
DR   AlphaFoldDB; Q8IZF2; -.
DR   SMR; Q8IZF2; -.
DR   BioGRID; 128719; 7.
DR   FunCoup; Q8IZF2; 68.
DR   IntAct; Q8IZF2; 8.
DR   STRING; 9606.ENSP00000283296; -.
DR   ChEMBL; CHEMBL4523888; -.
DR   MEROPS; P02.019; -.
DR   GlyConnect; Q8IZF2; 28 N-Linked glycans (14 sites).
DR   GlyCosmos; Q8IZF2; 27 sites, 68 glycans.
DR   GlyGen; Q8IZF2; 28 sites, 62 N-linked glycans (16 sites), 6 O-linked glycans (2 sites).
DR   iPTMnet; Q8IZF2; -.
DR   PhosphoSitePlus; Q8IZF2; -.
DR   BioMuta; ADGRF5; -.
DR   DMDM; 229462973; -.
DR   jPOST; Q8IZF2; -.
DR   MassIVE; Q8IZF2; -.
DR   PaxDb; 9606-ENSP00000283296; -.
DR   PeptideAtlas; Q8IZF2; -.
DR   ProteomicsDB; 71338; -. [Q8IZF2-1]
DR   ProteomicsDB; 71339; -. [Q8IZF2-2]
DR   ProteomicsDB; 71340; -. [Q8IZF2-3]
DR   Antibodypedia; 16896; 257 antibodies from 31 providers.
DR   DNASU; 221395; -.
DR   Ensembl; ENST00000265417.7; ENSP00000265417.6; ENSG00000069122.20. [Q8IZF2-1]
DR   Ensembl; ENST00000283296.12; ENSP00000283296.7; ENSG00000069122.20. [Q8IZF2-1]
DR   Ensembl; ENST00000888957.1; ENSP00000559016.1; ENSG00000069122.20. [Q8IZF2-1]
DR   Ensembl; ENST00000888963.1; ENSP00000559022.1; ENSG00000069122.20. [Q8IZF2-1]
DR   GeneID; 221395; -.
DR   KEGG; hsa:221395; -.
DR   MANE-Select; ENST00000283296.12; ENSP00000283296.7; NM_001098518.2; NP_001091988.1.
DR   UCSC; uc003oyo.5; human. [Q8IZF2-1]
DR   AGR; HGNC:19030; -.
DR   ClinPGx; PA134886165; -.
DR   CTD; 221395; -.
DR   DisGeNET; 221395; -.
DR   GeneCards; ADGRF5; -.
DR   HGNC; HGNC:19030; ADGRF5.
DR   HPA; ENSG00000069122; Tissue enhanced (lung).
DR   MIM; 620874; gene.
DR   OpenTargets; ENSG00000069122; -.
DR   VEuPathDB; HostDB:ENSG00000069122; -.
DR   eggNOG; KOG4193; Eukaryota.
DR   GeneTree; ENSGT00940000154603; -.
DR   HOGENOM; CLU_002753_3_5_1; -.
DR   InParanoid; Q8IZF2; -.
DR   OMA; AAESCTC; -.
DR   OrthoDB; 10040049at2759; -.
DR   PAN-GO; Q8IZF2; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; Q8IZF2; -.
DR   PathwayCommons; Q8IZF2; -.
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   SignaLink; Q8IZF2; -.
DR   Agora; ENSG00000069122; -.
DR   BioGRID-ORCS; 221395; 16 hits in 1149 CRISPR screens.
DR   ChiTaRS; ADGRF5; human.
DR   GeneWiki; GPR116; -.
DR   GenomeRNAi; 221395; -.
DR   Pharos; Q8IZF2; Tbio.
DR   PRO; PR:Q8IZF2; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q8IZF2; protein.
DR   Bgee; ENSG00000069122; Expressed in lower lobe of lung and 196 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0016020; C:membrane; TAS:GDB.
DR   GO; GO:0005886; C:plasma membrane; EXP:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0006112; P:energy reserve metabolic process; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:GDB.
DR   GO; GO:0042593; P:glucose homeostasis; IBA:GO_Central.
DR   GO; GO:0043129; P:surfactant homeostasis; IBA:GO_Central.
DR   CDD; cd15254; 7tmB2_GPR116_Ig-Hepta; 1.
DR   FunFam; 1.20.1070.10:FF:000058; Adhesion G protein-coupled receptor F5; 1.
DR   FunFam; 2.60.220.50:FF:000021; Adhesion G protein-coupled receptor F5; 1.
DR   FunFam; 2.60.40.10:FF:002239; Adhesion G protein-coupled receptor F5; 1.
DR   Gene3D; 2.60.220.50; -; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   Gene3D; 3.30.70.960; SEA domain; 1.
DR   InterPro; IPR057400; ADGRF3/5_N.
DR   InterPro; IPR051587; Adhesion_GPCR.
DR   InterPro; IPR057244; GAIN_B.
DR   InterPro; IPR046338; GAIN_dom_sf.
DR   InterPro; IPR017981; GPCR_2-like_7TM.
DR   InterPro; IPR008078; GPCR_2_Ig-hepta-like_rcpt.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   PANTHER; PTHR45813:SF4; ADHESION G PROTEIN-COUPLED RECEPTOR F5; 1.
DR   PANTHER; PTHR45813; IG-LIKE DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF25387; ADGRF3_N; 1.
DR   Pfam; PF01825; GPS; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   Pfam; PF01390; SEA; 1.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   PRINTS; PR01695; IGHEPTARCPTR.
DR   SMART; SM00303; GPS; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   SUPFAM; SSF82671; SEA domain; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
DR   PROSITE; PS50221; GAIN_B; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond;
KW   G protein-coupled receptor; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Proteomics identification; Receptor; Reference proteome;
KW   Repeat; Signal; Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..1346
FT                   /note="Adhesion G protein-coupled receptor F5"
FT                   /id="PRO_0000012896"
FT   TOPO_DOM        22..1006
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1007..1027
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1028..1053
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1054..1074
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1075..1090
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1091..1111
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1112..1128
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1129..1149
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1150..1173
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1174..1194
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1195..1220
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1221..1241
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1242..1244
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1245..1265
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1266..1346
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          166..273
FT                   /note="SEA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   DOMAIN          267..368
FT                   /note="Ig-like 1"
FT   DOMAIN          369..466
FT                   /note="Ig-like 2"
FT   DOMAIN          471..561
FT                   /note="Ig-like 3"
FT   DOMAIN          842..1003
FT                   /note="GAIN-B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   REGION          954..1003
FT                   /note="GPS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   REGION          991..1006
FT                   /note="Tethered agonist"
FT                   /evidence="ECO:0000269|PubMed:28570277,
FT                   ECO:0000269|PubMed:36073784"
FT   REGION          1327..1346
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1329..1346
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            51..52
FT                   /note="Cleavage; by furin"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVT0"
FT   SITE            226..227
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVT0"
FT   SITE            990..991
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098,
FT                   ECO:0000305|PubMed:36073784"
FT   MOD_RES         1300
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8Q8"
FT   MOD_RES         1307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8Q8"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        94
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        106
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        256
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        272
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        301
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        315
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        328
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        398
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        472
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        487
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        505
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        540
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        627
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        649
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        666
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        820
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        931
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        963
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        982
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        293..350
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        391..449
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        492..545
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        954..985
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   DISULFID        973..987
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   VAR_SEQ         272..414
FT                   /note="NESNFFVTPEIIFEGDTVSLVCEKEVLSSNVSWRYEEQQLEIQNSSRFSIYT
FT                   ALFNNMTSVSKLTIHNITPGDAGEYVCKLILDIFEYECKKKIDVMPIQILANEEMKVMC
FT                   DNNPVSLNCCSQGNVNWSKVEWKQEGKINIPG -> R (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039130"
FT   VAR_SEQ         1273..1292
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12435584"
FT                   /id="VSP_010837"
FT   VAR_SEQ         1322..1346
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12435584"
FT                   /id="VSP_010838"
FT   VARIANT         604
FT                   /note="T -> M (in dbSNP:rs586024)"
FT                   /evidence="ECO:0000269|PubMed:10048485,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005,
FT                   ECO:0000269|Ref.2"
FT                   /id="VAR_025326"
FT   VARIANT         801
FT                   /note="V -> I (in dbSNP:rs9395218)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_055291"
FT   VARIANT         856
FT                   /note="M -> T (in dbSNP:rs547499)"
FT                   /evidence="ECO:0000269|PubMed:10048485,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_024477"
FT   MUTAGEN         991..996
FT                   /note="Missing: No effect on activation by exogenous
FT                   ligands, nor on subcellular location. Loss of activation by
FT                   exogenous ligands; when associated with 1240-I--S-1243.
FT                   Increased activation by exogenous agonists; when associated
FT                   with K-l009 or with T-1252 or A-1256."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1009
FT                   /note="G->K: No effect on activation by exogenous agonist.
FT                   Increased activation by exogenous agonist; when associated
FT                   with 991-T--L-996 del."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1075..1077
FT                   /note="QDN->HDG: No effect on activation by exogenous
FT                   agonist."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1080..1083
FT                   /note="ILCK->PLNE: No effect on activation by exogenous
FT                   agonist."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1153
FT                   /note="R->Q: No effect on activation by exogenous agonist;
FT                   when associated with M-1157 and A-1161."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1157
FT                   /note="T->M: No effect on activation by exogenous agonist;
FT                   when associated with Q-1153 and A-1161."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1161
FT                   /note="V->A: No effect on activation by exogenous agonist;
FT                   when associated with Q-1153 and M-1157."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1240..1243
FT                   /note="FPGT->IQGS: Loss of activation by exogenous ligand;
FT                   when associated with 991-T--L-996 del."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1252
FT                   /note="A->T: Increased activation by exogenous agonists;
FT                   when associated with 991-T--L-996 del."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   MUTAGEN         1256
FT                   /note="V->A: Increased activation by exogenous agonists;
FT                   when associated with 991-T--L-996 del."
FT                   /evidence="ECO:0000269|PubMed:36073784"
FT   CONFLICT        272
FT                   /note="Missing (in Ref. 1; AAN46672)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        573
FT                   /note="V -> I (in Ref. 7; CAB43394)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1075
FT                   /note="Q -> R (in Ref. 5; AL832125)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1346 AA;  149457 MW;  72A9D02B08218A60 CRC64;
     MKSPRRTTLC LMFIVIYSSK AALNWNYEST IHPLSLHEHE PAGEEALRQK RAVATKSPTA
     EEYTVNIEIS FENASFLDPI KAYLNSLSFP IHGNNTDQIT DILSINVTTV CRPAGNEIWC
     SCETGYGWPR ERCLHNLICQ ERDVFLPGHH CSCLKELPPN GPFCLLQEDV TLNMRVRLNV
     GFQEDLMNTS SALYRSYKTD LETAFRKGYG ILPGFKGVTV TGFKSGSVVV TYEVKTTPPS
     LELIHKANEQ VVQSLNQTYK MDYNSFQAVT INESNFFVTP EIIFEGDTVS LVCEKEVLSS
     NVSWRYEEQQ LEIQNSSRFS IYTALFNNMT SVSKLTIHNI TPGDAGEYVC KLILDIFEYE
     CKKKIDVMPI QILANEEMKV MCDNNPVSLN CCSQGNVNWS KVEWKQEGKI NIPGTPETDI
     DSSCSRYTLK ADGTQCPSGS SGTTVIYTCE FISAYGARGS ANIKVTFISV ANLTITPDPI
     SVSEGQNFSI KCISDVSNYD EVYWNTSAGI KIYQRFYTTR RYLDGAESVL TVKTSTREWN
     GTYHCIFRYK NSYSIATKDV IVHPLPLKLN IMVDPLEATV SCSGSHHIKC CIEEDGDYKV
     TFHTGSSSLP AAKEVNKKQV CYKHNFNASS VSWCSKTVDV CCHFTNAANN SVWSPSMKLN
     LVPGENITCQ DPVIGVGEPG KVIQKLCRFS NVPSSPESPI GGTITYKCVG SQWEEKRNDC
     ISAPINSLLQ MAKALIKSPS QDEMLPTYLK DLSISIDKAE HEISSSPGSL GAIINILDLL
     STVPTQVNSE MMTHVLSTVN VILGKPVLNT WKVLQQQWTN QSSQLLHSVE RFSQALQSGD
     SPPLSFSQTN VQMSSMVIKS SHPETYQQRF VFPYFDLWGN VVIDKSYLEN LQSDSSIVTM
     AFPTLQAILA QDIQENNFAE SLVMTTTVSH NTTMPFRISM TFKNNSPSGG ETKCVFWNFR
     LANNTGGWDS SGCYVEEGDG DNVTCICDHL TSFSILMSPD SPDPSSLLGI LLDIISYVGV
     GFSILSLAAC LVVEAVVWKS VTKNRTSYMR HTCIVNIAAS LLVANTWFIV VAAIQDNRYI
     LCKTACVAAT FFIHFFYLSV FFWMLTLGLM LFYRLVFILH ETSRSTQKAI AFCLGYGCPL
     AISVITLGAT QPREVYTRKN VCWLNWEDTK ALLAFAIPAL IIVVVNITIT IVVITKILRP
     SIGDKPCKQE KSSLFQISKS IGVLTPLLGL TWGFGLTTVF PGTNLVFHII FAILNVFQGL
     FILLFGCLWD LKVQEALLNK FSLSRWSSQH SKSTSLGSST PVFSMSSPIS RRFNNLFGKT
     GTYNVSTPEA TSSSLENSSS ASSLLN
//
DBGET integrated database retrieval system